Best way to monetize invention machine is not to sell it, but to use it yourself
A viral argument claims the real value of AGI lies in solving humanity's biggest problems, not commercial licensing.
A thought-provoking argument gaining traction online posits a radical shift in how we think about monetizing advanced artificial intelligence. Instead of the conventional path of selling or licensing a powerful AI 'invention machine'—a proxy for Artificial General Intelligence (AGI)—the post contends the highest-value strategy is to deploy the technology directly against humanity's most intractable problems. The core thesis is that the economic and societal returns from solving a challenge like curing cancer would dwarf any revenue from simply commercializing the underlying AGI technology as a product or service.
This perspective reframes the endgame for AGI development. It suggests the ultimate benchmark for success isn't just creating a super-intelligent system, but directing that system toward a specific, world-changing outcome. The post uses 'curing cancer' as a symbolic final goal post, representing a class of complex, high-stakes problems that require breakthrough innovation. This view challenges incumbent business models in the AI space, implying that the entities which build such powerful systems might reap greater rewards by becoming applied problem-solvers themselves, rather than remaining pure technology vendors.
- The post argues direct application of AGI to solve major problems like cancer is more valuable than selling the technology.
- It reframes the 'final goal post' for AGI from mere creation to achieving specific, monumental breakthroughs.
- This challenges traditional tech commercialization models, suggesting the builder should also be the primary user for maximum impact.
Why It Matters
It forces a rethink of AI's business model and ultimate purpose, prioritizing direct societal impact over indirect commercialization.